{"id":120058,"date":"2026-06-17T11:09:24","date_gmt":"2026-06-17T05:39:24","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=120058"},"modified":"2026-06-17T11:09:25","modified_gmt":"2026-06-17T05:39:25","slug":"anuh-pharma-share-price-target-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/","title":{"rendered":"Anuh Pharma Share Price Target 2026 Analyst Forecast Bull and Bear Case"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>The Anuh Pharma share price target 2026 is Rs 93.3, implying approximately 20 percent upside from the current market price of Rs 77.77 (NSE: ANUHPHR). With Q4 FY26 results released in 2026 and Pharmaceutical Formulations and APIs sector tailwinds in focus, the Rs 93.3 price objective is supported by the FY27 earnings recovery thesis.<\/em><\/p>\n<p><a href=\"https:\/\/univest.in\/user\/stocks\/anuhphr\/anuh-pharma-ltd-share-price-today\">Anuh Pharma<\/a> (NSE: ANUHPHR) is a Pharmaceutical Formulations and APIs company trading at Rs 77.77 with a market capitalisation of Rs 389 crore. Analysts have set the <strong>Anuh Pharma share price target<\/strong> at Rs 93.3 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast for Anuh Pharma including sector tailwinds, key risks, and bull and bear scenarios.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Anuh_Pharma_Share_Price_Target_2026_Key_Takeaways\" title=\"Anuh Pharma Share Price Target 2026: Key Takeaways\">Anuh Pharma Share Price Target 2026: Key Takeaways<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Anuh_Pharma_Company_Overview\" title=\"Anuh Pharma Company Overview\">Anuh Pharma Company Overview<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Why_Is_the_Anuh_Pharma_Share_Price_Target_Set_at_Rs_933_for_2026\" title=\"Why Is the Anuh Pharma Share Price Target Set at Rs 93.3 for 2026\">Why Is the Anuh Pharma Share Price Target Set at Rs 93.3 for 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#FY27_Earnings_Recovery_and_Revenue_Acceleration\" title=\"FY27 Earnings Recovery and Revenue Acceleration\">FY27 Earnings Recovery and Revenue Acceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Structural_Sector_Tailwinds_in_Pharmaceutical_Formulations_and_APIs\" title=\"Structural Sector Tailwinds in Pharmaceutical Formulations and APIs\">Structural Sector Tailwinds in Pharmaceutical Formulations and APIs<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\" title=\"RBI Rate Cut Cycle and Lower Cost of Capital\">RBI Rate Cut Cycle and Lower Cost of Capital<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Union_Budget_2026-27_Capex_Push_and_Policy_Support\" title=\"Union Budget 2026-27 Capex Push and Policy Support\">Union Budget 2026-27 Capex Push and Policy Support<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#FII_Flow_Normalisation_After_the_2026_Tariff_Shock\" title=\"FII Flow Normalisation After the 2026 Tariff Shock\">FII Flow Normalisation After the 2026 Tariff Shock<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Anuh_Pharma_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\" title=\"Anuh Pharma Share Price Targets: Short Term, 12 Month, and Long Term\">Anuh Pharma Share Price Targets: Short Term, 12 Month, and Long Term<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Short_Term_Anuh_Pharma_Share_Price_Target\" title=\"Short Term Anuh Pharma Share Price Target\">Short Term Anuh Pharma Share Price Target<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#12-Month_Anuh_Pharma_Share_Price_Target_2026\" title=\"12-Month Anuh Pharma Share Price Target 2026\">12-Month Anuh Pharma Share Price Target 2026<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Long_Term_Anuh_Pharma_Share_Price_Target_FY27_to_FY28\" title=\"Long Term Anuh Pharma Share Price Target: FY27 to FY28\">Long Term Anuh Pharma Share Price Target: FY27 to FY28<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Bull_Case_and_Bear_Case_Scenarios_for_Anuh_Pharma_in_2026\" title=\"Bull Case and Bear Case Scenarios for Anuh Pharma in 2026\">Bull Case and Bear Case Scenarios for Anuh Pharma in 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Bull_Case_Anuh_Pharma_Share_Price_Target_Rs_115\" title=\"Bull Case Anuh Pharma Share Price Target: Rs 115\">Bull Case Anuh Pharma Share Price Target: Rs 115<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Bear_Case_Anuh_Pharma_Share_Price_Target_Rs_622\" title=\"Bear Case Anuh Pharma Share Price Target: Rs 62.2\">Bear Case Anuh Pharma Share Price Target: Rs 62.2<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Key_Risks_That_Could_Derail_the_Anuh_Pharma_2026_Price_Objective\" title=\"Key Risks That Could Derail the Anuh Pharma 2026 Price Objective\">Key Risks That Could Derail the Anuh Pharma 2026 Price Objective<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Global_Macro_and_US_Tariff_Headwinds\" title=\"Global Macro and US Tariff Headwinds\">Global Macro and US Tariff Headwinds<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#FY27_Earnings_Miss_and_Guidance_Risk\" title=\"FY27 Earnings Miss and Guidance Risk\">FY27 Earnings Miss and Guidance Risk<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Competitive_Intensity_Among_Pharmaceutical_Formulations_and_APIs_Peers\" title=\"Competitive Intensity Among Pharmaceutical Formulations and APIs Peers\">Competitive Intensity Among Pharmaceutical Formulations and APIs Peers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Liquidity_Risk_and_FII_Selling_Pressure\" title=\"Liquidity Risk and FII Selling Pressure\">Liquidity Risk and FII Selling Pressure<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#How_to_Invest_in_Anuh_Pharma\" title=\"How to Invest in Anuh Pharma\">How to Invest in Anuh Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#FAQs_on_Anuh_Pharma_Share_Price_Target_2026\" title=\"FAQs on Anuh Pharma Share Price Target 2026\">FAQs on Anuh Pharma Share Price Target 2026<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#What_is_the_Anuh_Pharma_share_price_target_for_2026\" title=\"What is the Anuh Pharma share price target for 2026?\">What is the Anuh Pharma share price target for 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#What_was_the_Anuh_Pharma_share_price_target_for_2025\" title=\"What was the Anuh Pharma share price target for 2025?\">What was the Anuh Pharma share price target for 2025?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#Is_Anuh_Pharma_a_good_investment_at_Rs_7777\" title=\"Is Anuh Pharma a good investment at Rs 77.77?\">Is Anuh Pharma a good investment at Rs 77.77?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#What_are_the_key_risks_to_the_Anuh_Pharma_share_price_target_2026\" title=\"What are the key risks to the Anuh Pharma share price target 2026?\">What are the key risks to the Anuh Pharma share price target 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#What_is_the_52_week_high_and_low_of_Anuh_Pharma\" title=\"What is the 52 week high and low of Anuh Pharma?\">What is the 52 week high and low of Anuh Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#What_are_the_main_growth_catalysts_for_Anuh_Pharma_in_2026\" title=\"What are the main growth catalysts for Anuh Pharma in 2026?\">What are the main growth catalysts for Anuh Pharma in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#How_does_Anuh_Pharma_compare_to_its_peers\" title=\"How does Anuh Pharma compare to its peers?\">How does Anuh Pharma compare to its peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/univest.in\/blogs-2\/anuh-pharma-share-price-target-2026\/#What_is_the_Anuh_Pharma_share_price_target_for_2027\" title=\"What is the Anuh Pharma share price target for 2027?\">What is the Anuh Pharma share price target for 2027?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Anuh_Pharma_Share_Price_Target_2026_Key_Takeaways\"><\/span><strong>Anuh Pharma Share Price Target 2026: Key Takeaways<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Anuh Pharma share price target 2026:<\/strong> Rs 93.3 (20% upside from CMP Rs 77.77)<\/li>\n<li><strong>Bull case:<\/strong> Rs 115 | <strong>Bear case:<\/strong> Rs 62.2<\/li>\n<li><strong>Ticker:<\/strong> ANUHPHR | <strong>Sector:<\/strong> Pharmaceutical Formulations and APIs | <strong>MCap:<\/strong> Rs 389 crore<\/li>\n<li><strong>52W range:<\/strong> Rs 55 to Rs 139 | <strong>PE:<\/strong> 15x<\/li>\n<li><strong>Key catalyst:<\/strong> Q4 FY26 results and FY27 earnings confirmation in 2026<\/li>\n<li><strong>Key risk:<\/strong> FY27 earnings miss or FII outflows from Indian equities<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Anuh_Pharma_Company_Overview\"><\/span><strong>Anuh Pharma Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Anuh Pharma (NSE: ANUHPHR) is a Mumbai-based pharmaceutical company manufacturing sulpha drugs, antibiotic formulations, and pharmaceutical intermediates for domestic hospital distribution and export. At CMP Rs 77.77 against a 52 week range of Rs 55 to Rs 139, the stock trades at a meaningful discount to its 52 week high. Market capitalisation is Rs 389 crore with trailing PE of 15x. Compared to peers in pharma like Kilitch Drugs and Bal Pharma, Anuh Pharma is positioned as a potential re-rating candidate toward the Rs 93.3 price objective on FY27 earnings delivery.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>ANUHPHR<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceutical Formulations and APIs<\/td>\n<\/tr>\n<tr>\n<td>CMP (2026)<\/td>\n<td>Rs 77.77<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 139<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 55<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 389 crore<\/td>\n<\/tr>\n<tr>\n<td>Trailing PE<\/td>\n<td>15x<\/td>\n<\/tr>\n<tr>\n<td>12-Month Analyst Target<\/td>\n<td>Rs 93.3<\/td>\n<\/tr>\n<tr>\n<td>Bull Case Target<\/td>\n<td>Rs 115<\/td>\n<\/tr>\n<tr>\n<td>Bear Case Target<\/td>\n<td>Rs 62.2<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background: #E8EAFF; border-radius: 14px; padding: 28px 32px 24px 32px; margin: 24px 0; font-family: -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,sans-serif; cursor: pointer; max-width: 100%; box-sizing: border-box;\">\n<p style=\"font-size: 20px; font-weight: bold; color: #0a0a23; margin: 0 0 12px 0; line-height: 1.3;\">3 Stocks Building Serious Momentum Right Now<\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">When <strong style=\"color: #0a0a23;\">Univest analysts<\/strong> identify high-conviction opportunities, <em>investors pay attention.<\/em><\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">Our research team has shortlisted the <strong style=\"color: #0a0a23;\">Top Stocks to Buy<\/strong> based on market momentum, sector trends &amp; growth potential for 2026.<\/p>\n<ul style=\"margin: 0 0 16px 20px; padding: 0; color: #3a3a5c; font-size: 15px; line-height: 1.8;\">\n<li>Discover stocks investors are actively accumulating<\/li>\n<li>High-conviction opportunities backed by research<\/li>\n<li>Designed for the next phase of market growth<\/li>\n<\/ul>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 20px 0;\">Unlock the latest <a style=\"color: #3b7fff; font-weight: bold; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">Top Stock Picks<\/a> now on Univest<\/p>\n<p><a style=\"display: inline-block; background: #3B7FFF; color: #fff; font-size: 15px; font-weight: 600; padding: 13px 28px; border-radius: 50px; letter-spacing: 0.2px; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">See the Stocks \u2192<\/a><\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_the_Anuh_Pharma_Share_Price_Target_Set_at_Rs_933_for_2026\"><\/span><strong>Why Is the Anuh Pharma Share Price Target Set at Rs 93.3 for 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Recovery_and_Revenue_Acceleration\"><\/span><strong>FY27 Earnings Recovery and Revenue Acceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>Anuh Pharma share price target<\/strong> of Rs 93.3 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for a re-rating from CMP Rs 77.77. Until FY27 PAT delivery is confirmed, the Rs 93.3 objective represents a base case with execution risk attached.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Structural_Sector_Tailwinds_in_Pharmaceutical_Formulations_and_APIs\"><\/span><strong>Structural Sector Tailwinds in Pharmaceutical Formulations and APIs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Pharmaceutical Formulations and APIs sector is expanding on the back of India&#8217;s domestic demand growth, PLI scheme support, and rising corporate investment. Anuh Pharma&#8217;s market position among peers in pharma like Kilitch Drugs and Bal Pharma creates a structural growth runway. Sustained sector outperformance is one of the key conditions for the Rs 115 bull case to materialise, making sector monitoring essential for investors tracking the stock.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"RBI_Rate_Cut_Cycle_and_Lower_Cost_of_Capital\"><\/span><strong>RBI Rate Cut Cycle and Lower Cost of Capital<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s RBI rate cut cycle in 2026 is reducing borrowing costs across sectors and stimulating end market demand. For Anuh Pharma, lower interest costs improve the EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 93.3 analyst consensus in 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Union_Budget_2026-27_Capex_Push_and_Policy_Support\"><\/span><strong>Union Budget 2026-27 Capex Push and Policy Support<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Budget 2026-27&#8217;s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a favourable policy backdrop for Anuh Pharma&#8217;s Pharmaceutical Formulations and APIs operations. Policy support increases the probability of Anuh Pharma achieving its FY27 earnings targets, supporting the Rs 93.3 price objective.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FII_Flow_Normalisation_After_the_2026_Tariff_Shock\"><\/span><strong>FII Flow Normalisation After the 2026 Tariff Shock<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 15x PE, Anuh Pharma is positioned as a beneficiary of institutional reallocation into the Pharmaceutical Formulations and APIs sector, providing a tailwind toward the Rs 115 bull case.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Anuh_Pharma_Share_Price_Targets_Short_Term_12_Month_and_Long_Term\"><\/span><strong>Anuh Pharma Share Price Targets: Short Term, 12 Month, and Long Term<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Short_Term_Anuh_Pharma_Share_Price_Target\"><\/span><strong>Short Term Anuh Pharma Share Price Target<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Near-term support for Anuh Pharma is anchored close to the 52 week low of Rs 55. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating. Investors eyeing a near-term entry can use the 52 week low as a reference while awaiting the FY27 earnings confirmation that would support the full Rs 93.3 objective.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"12-Month_Anuh_Pharma_Share_Price_Target_2026\"><\/span><strong>12-Month Anuh Pharma Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The 12-month <strong>Anuh Pharma share price target 2026<\/strong> is Rs 93.3, implying approximately 20 percent upside from CMP Rs 77.77. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows into the Pharmaceutical Formulations and APIs sector. Track live price on NSE under ticker ANUHPHR.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Long_Term_Anuh_Pharma_Share_Price_Target_FY27_to_FY28\"><\/span><strong>Long Term Anuh Pharma Share Price Target: FY27 to FY28<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>long term Anuh Pharma share price target<\/strong> for FY27 to FY28 is Rs 115 in the bull case. Full earnings delivery, re-rating toward higher peer multiples among peers in pharma like Kilitch Drugs and Bal Pharma, and sustained institutional buying are the three conditions needed to reach Rs 115 over a 2 to 3 year horizon.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Bull_Case_and_Bear_Case_Scenarios_for_Anuh_Pharma_in_2026\"><\/span><strong>Bull Case and Bear Case Scenarios for Anuh Pharma in 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Bull_Case_Anuh_Pharma_Share_Price_Target_Rs_115\"><\/span><strong>Bull Case Anuh Pharma Share Price Target: Rs 115<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>bull case Anuh Pharma share price target<\/strong> of Rs 115 materialises when FY27 earnings beat analyst estimates, Pharmaceutical Formulations and APIs tailwinds accelerate, and FII flows return strongly to Indian equities. Under this scenario, Anuh Pharma re-rates toward higher peer multiples, making Rs 115 achievable within FY28, representing approximately 45 percent upside from the current CMP of Rs 77.77.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Bear_Case_Anuh_Pharma_Share_Price_Target_Rs_622\"><\/span><strong>Bear Case Anuh Pharma Share Price Target: Rs 62.2<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The <strong>bear case Anuh Pharma share price target<\/strong> of Rs 62.2 materialises if FY27 earnings disappoint or FII outflows depress the broader market. Under this scenario, the stock risks testing 52 week low support near Rs 55, and investors should reassess the thesis before deploying additional capital.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Scenario<\/th>\n<th>Target<\/th>\n<th>Key Conditions<\/th>\n<\/tr>\n<tr>\n<td>Bull Case<\/td>\n<td>Rs 115<\/td>\n<td>FY27 earnings beat, sector re-rating, FII inflows<\/td>\n<\/tr>\n<tr>\n<td>Base Case (Analyst Target)<\/td>\n<td>Rs 93.3<\/td>\n<td>In-line FY27 delivery, partial FII recovery<\/td>\n<\/tr>\n<tr>\n<td>Bear Case<\/td>\n<td>Rs 62.2<\/td>\n<td>FY27 miss, guidance cut, FII outflows persist<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_That_Could_Derail_the_Anuh_Pharma_2026_Price_Objective\"><\/span><strong>Key Risks That Could Derail the Anuh Pharma 2026 Price Objective<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Global_Macro_and_US_Tariff_Headwinds\"><\/span><strong>Global Macro and US Tariff Headwinds<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Prolonged tariff tensions triggered by the US reciprocal tariff announcement in 2026 have reduced FII risk appetite for Indian equities. A global demand slowdown or escalation in trade tensions remains a prominent macro risk to the <strong>Anuh Pharma share price target<\/strong> of Rs 93.3 and could push the stock toward the bear case of Rs 62.2.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"FY27_Earnings_Miss_and_Guidance_Risk\"><\/span><strong>FY27 Earnings Miss and Guidance Risk<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>An FY27 earnings miss or downward guidance revision would compress multiples. This is the most direct company-specific risk to the Rs 93.3 analyst price objective. Investors should monitor quarterly results and management commentary, especially signals about demand environment, pricing power, and margin compression in Pharmaceutical Formulations and APIs.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Competitive_Intensity_Among_Pharmaceutical_Formulations_and_APIs_Peers\"><\/span><strong>Competitive Intensity Among Pharmaceutical Formulations and APIs Peers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Intensifying competition from peers in pharma like Kilitch Drugs and Bal Pharma could compress Anuh Pharma&#8217;s market share and pricing power over the medium term. This structural risk must be weighed when assessing how defensible the earnings trajectory is that underpins the Rs 93.3 analyst target for 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Liquidity_Risk_and_FII_Selling_Pressure\"><\/span><strong>Liquidity Risk and FII Selling Pressure<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level improvement. For smaller market cap stocks, liquidity constraints can amplify drawdowns. Investors should size positions carefully and maintain stop losses to protect capital if broader market de-rating continues.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Invest_in_Anuh_Pharma\"><\/span><strong>How to Invest in Anuh Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data<\/strong><\/a><\/p>\n<p>Before considering any investment based on the <strong>Anuh Pharma share price target<\/strong> of Rs 93.3, review the company&#8217;s Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, operating margin trends, debt levels, and management commentary on Pharmaceutical Formulations and APIs sector demand and competition.<\/p>\n<p>Open a Demat and trading account with a SEBI registered stockbroker to trade Anuh Pharma (NSE: ANUHPHR) with regulatory protection. Before executing any order, study the competitive landscape among peers in pharma like Kilitch Drugs and Bal Pharma to assess whether Anuh Pharma&#8217;s competitive position justifies the Rs 93.3 valuation.<\/p>\n<p>Plan your entry using the 52 week low of Rs 55 as a key support reference. A confirmed FY27 earnings uptick combined with positive guidance would validate the entry case. Always set a pre-defined stop loss below the 52 week low to limit downside.<\/p>\n<p>Maintain position sizing discipline. Restrict any single stock to 3 to 5 percent of your total equity portfolio, especially in the Pharmaceutical Formulations and APIs space where sectoral cycles can amplify volatility beyond initial expectations.<\/p>\n<p>Always consult a SEBI registered financial advisor before making investment decisions based on any analyst price target or market commentary. SEBI Registration No. INH000013776.<\/p>\n<p><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or the <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Anuh Pharma&#8217;s live share price and receive daily stock recommendations from SEBI registered analysts.<\/em><\/p>\n<div style=\"background: #C0392B; padding: 20px 24px; border-radius: 4px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 15px; font-weight: bold; margin: 0; line-height: 1.7;\"><strong>Disclaimer Note:<\/strong> The securities quoted, if any, are for illustration only and are not recommendatory. This content is for educational purposes only and does not constitute investment advice. Investments in securities are subject to market risk. Read all related documents carefully before investing. SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Anuh_Pharma_Share_Price_Target_2026\"><\/span><strong>FAQs on Anuh Pharma Share Price Target 2026<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Anuh_Pharma_share_price_target_for_2026\"><\/span><strong>What is the Anuh Pharma share price target for 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Anuh Pharma share price target 2026 is Rs 93.3, implying approximately 20 percent upside from CMP Rs 77.77. The bull case target is Rs 115 and the bear case is Rs 62.2.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Anuh_Pharma_share_price_target_for_2025\"><\/span><strong>What was the Anuh Pharma share price target for 2025?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 2025 price objective for Anuh Pharma was based on FY26 earnings projections. The current 2026 analyst consensus is Rs 93.3, reflecting FY27 growth potential from the current CMP of Rs 77.77.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Anuh_Pharma_a_good_investment_at_Rs_7777\"><\/span><strong>Is Anuh Pharma a good investment at Rs 77.77?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> At Rs 77.77, Anuh Pharma offers potential upside toward Rs 93.3 if FY27 earnings recover as projected. Whether this represents a good entry depends on individual risk tolerance and portfolio goals. Consult a SEBI registered financial advisor before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_to_the_Anuh_Pharma_share_price_target_2026\"><\/span><strong>What are the key risks to the Anuh Pharma share price target 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key risks to the Anuh Pharma share price target of Rs 93.3 include FY27 earnings miss, global tariff headwinds, FII outflows, and competitive pressure in Pharmaceutical Formulations and APIs. Monitoring quarterly results and management guidance is essential.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_Anuh_Pharma\"><\/span><strong>What is the 52 week high and low of Anuh Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52 week high of Anuh Pharma is Rs 139 and the 52 week low is Rs 55. At CMP Rs 77.77, the stock is trading below its 52 week high and offers upside toward the Rs 93.3 analyst price objective.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_main_growth_catalysts_for_Anuh_Pharma_in_2026\"><\/span><strong>What are the main growth catalysts for Anuh Pharma in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Primary growth catalysts for Anuh Pharma in 2026 include FY27 PAT recovery, Pharmaceutical Formulations and APIs sector tailwinds, RBI rate cuts reducing cost of capital, Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Anuh_Pharma_compare_to_its_peers\"><\/span><strong>How does Anuh Pharma compare to its peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Anuh Pharma operates in Pharmaceutical Formulations and APIs alongside peers in pharma like Kilitch Drugs and Bal Pharma. At CMP Rs 77.77 with MCap Rs 389 crore, the company is positioned as a potential re-rating candidate toward the Anuh Pharma share price target of Rs 93.3 on FY27 earnings delivery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_Anuh_Pharma_share_price_target_for_2027\"><\/span><strong>What is the Anuh Pharma share price target for 2027?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The long-term Anuh Pharma share price target for FY27 to FY28 is Rs 115 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows into Indian equities. Consult a SEBI registered financial advisor for personalised guidance.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Anuh Pharma share price target 2026 is Rs 93.3, ~20% upside from CMP Rs 77.77. Bull Rs 115, bear Rs 62.2. 2026.<\/p>\n","protected":false},"author":35,"featured_media":120461,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-120058","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1781674770:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["83"],"rank_math_title":["Anuh Pharma Share Price Target 2026: Rs 93.3 Analyst Forecast"],"rank_math_description":["The Anuh Pharma share price target 2026 is Rs 93.3, ~20% upside from CMP Rs 77.77. Bull Rs 115, bear Rs 62.2. 2026."],"rank_math_focus_keyword":["Anuh Pharma share price target"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_wp_old_date":["2026-06-16"],"_thumbnail_id":["120461"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["18582"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Anuh-Pharma-Share-Price-Target-2026-Analyst-Forecast-Bull-and-Bear-Case.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/120058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=120058"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/120058\/revisions"}],"predecessor-version":[{"id":120462,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/120058\/revisions\/120462"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/120461"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=120058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=120058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=120058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}